KG
Kumarapuram Gopalakrishnan Ananthakrishnan
About Kumarapuram Gopalakrishnan Ananthakrishnan
Data last updated:
Kumarapuram Gopalakrishnan Ananthakrishnan is a Director at Rubicon Research Limited (since 2024), Director at Gujarat Themis Biosyn Ltd (since 2024) and Director at Sapala Organics Private Limited (since 2024), and holds 2 more current directorships. The companies operate in Chemicals, Pharma and Chemicals and Materials. The 4 current companies with reported revenue have a combined latest revenue of ₹1,102 Cr; the largest is Rubicon Research Limited at ₹872 Cr (FY 2024). Earlier, Kumarapuram Gopalakrishnan Ananthakrishnan was a Director at Ascent Meditech Limited (2019–2023) and Director at Organisation Of Pharmaceutical Producers Of India (2006–2017) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Jun 2024 | 1999 | ₹872 Cr (FY 2024) | Active | |
| Director | 26 Jul 2024 | 1981 | ₹153 Cr (FY 2025) | Active | |
| Director | 31 Jul 2024 | 2005 | ₹75.59 Cr (FY 2024) | Active | |
| Director | 13 Dec 2024 | 2021 | ₹36.8 Lakh (FY 2024) | Active | |
| Director | 29 Sep 2023 |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Feb 2019 | 2012 | ₹183 Cr (FY 2025) | Active | |
| Director | 21 Dec 2006 | 1965 | ₹15.58 Cr (FY 2025) | Active | |
| Director | 17 Apr 2008 | 1967 | ₹135 Cr (FY 2025) | Active | |
| Managing Director | 26 Mar 2007 | 1948 | ₹95.86 Cr (FY 2025) | Active | |
| Managing Director | 15 Feb 2010 | 2004 | ₹2,749 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kumarapuram Gopalakrishnan Ananthakrishnan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kumarapuram Gopalakrishnan Ananthakrishnan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumarapuram Gopalakrishnan Ananthakrishnan
Kumarapuram Gopalakrishnan Ananthakrishnan currently holds 5 directorships: Rubicon Research Limited (Director, since 11 Jun 2024, revenue ₹872 Cr (FY 2024)); Gujarat Themis Biosyn Ltd (Director, since 26 Jul 2024, revenue ₹153 Cr (FY 2025)); Sapala Organics Private Limited (Director, since 31 Jul 2024, revenue ₹75.59 Cr (FY 2024)); Mango Care Foundation (Director, since 13 Dec 2024, revenue ₹36.8 Lakh (FY 2024)); Cohance Lifesciences Limited (Director, since 29 Sep 2023).
Kumarapuram Gopalakrishnan Ananthakrishnan was first appointed on 21 Dec 2006 as Director at Organisation Of Pharmaceutical Producers Of India. The most recent appointment on record is 13 Dec 2024 at Mango Care Foundation.
The 4 current companies of Kumarapuram Gopalakrishnan Ananthakrishnan that report revenue have a combined latest revenue of ₹1,102 Cr: Rubicon Research Limited ₹872 Cr (FY 2024); Gujarat Themis Biosyn Ltd ₹153 Cr (FY 2025); Sapala Organics Private Limited ₹75.59 Cr (FY 2024); Mango Care Foundation ₹36.8 Lakh (FY 2024).
Kumarapuram Gopalakrishnan Ananthakrishnan held 5 earlier board appointments: Ascent Meditech Limited (Director, 05 Feb 2019 to 26 May 2023); Organisation Of Pharmaceutical Producers Of India (Director, 21 Dec 2006 to 28 Feb 2017); Organon (India) Private Limited (Director, 17 Apr 2008 to 01 Mar 2017); Fulford (India) Private Limited (Managing Director, 26 Mar 2007 to 01 Mar 2017); Msd Pharmaceuticals Private Limited (Managing Director, 15 Feb 2010 to 01 Mar 2017).
The current boards of Kumarapuram Gopalakrishnan Ananthakrishnan's companies include Changavalli Venkat (Rubicon Research Limited), Deepashree Omkar Tanksale (Rubicon Research Limited), Milind Anil Patil (Rubicon Research Limited), Nitin Jajodia (Rubicon Research Limited), Parag Suganchand Sancheti (Rubicon Research Limited), Parag Suganchand Sancheti (Rubicon Research Limited), among others.